Yellow Fever Outbreak in the Americas: A Growing Health Threat

A concerning rise in yellow fever cases is impacting several countries in the Americas, prompting health organizations to issue alerts and emphasize the importance of vaccination. From late 2024 through early 2026, Bolivia, Brazil, Colombia, Ecuador, Guyana, and Peru have reported a significant increase in infections, raising concerns about broader geographic spread and potential health impacts.

Current Situation and Case Numbers

As of April 26, 2025, a total of 212 confirmed human cases of yellow fever, including 85 deaths, have been reported to the World Health Organization (WHO) by five countries in the Region of the Americas [1]. This represents a threefold increase compared to the 61 confirmed cases reported in 2024. The case fatality rate currently stands at 40%.

In Bolivia, an outbreak of chikungunya is as well occurring in the Santa Cruz and Cochabamba Departments, adding to the public health challenges [1].

Symptoms and Clinical Phases

Yellow fever is an acute febrile hemorrhagic infectious disease caused by a virus transmitted through the bite of infected mosquitoes. The disease progresses through three clinical phases:

• Suspected Case: Individuals with acute fever (lasting up to 7 days) who have resided in or visited a transmission area within the last 15 days, are unvaccinated or have unknown vaccination status, and exhibit symptoms like jaundice or hemorrhagic manifestations (e.g., nosebleeds, bleeding gums, blood in vomit, feces, or urine).
• Probable Case: A suspected case with positive IgM for yellow fever (without recent vaccination) or an epidemiological link to a confirmed case or outbreak within the previous month.
• Confirmed Case: A probable case with negative tests for other endemic Flaviviruses, seroconversion in neutralization tests, or a suspected case with viral genome detection (RT-PCR) or antigen detection in organs via immunohistochemistry.

Prevention: Vaccination is Key

Vaccination remains the most effective means of preventing yellow fever. Health authorities strongly urge citizens to ensure they are up-to-date on their immunization schedules, particularly when living in or traveling to at-risk areas. The CDC recommends all international travelers be fully vaccinated against measles with the measles-mumps-rubella (MMR) vaccine [1] and [3].

Travelers planning to visit Venezuela are advised to get vaccinated against yellow fever at least 10 days before arrival, especially if visiting states like Aragua, Barinas, Lara, and Portuguesa, or jungle areas [4].

Regional Impact and Venezuela’s Situation

The current epidemiological situation indicates a reactivation of the jungle transmission cycle in the Amazon basin, affecting a wider geographic area than in previous years. Venezuela is classified as an endemic country, with over 70% of its states (17 of 24) presenting conditions conducive to yellow fever transmission [4]. As of February 4, 2025, Venezuela had confirmed 36 cases of yellow fever since June of the previous year [4].

Global Context and Other Health Concerns

Beyond yellow fever, there is an elevated risk of chikungunya in Brazil [3] and an ongoing global increase in measles cases [1] and [3]. Staying informed about current health issues and taking preventative measures is crucial for travelers.

Key Takeaways

• Yellow fever cases are significantly increasing in the Americas.
• Vaccination is the primary prevention method.
• Symptoms include fever, jaundice, and hemorrhagic manifestations.
• Travelers to affected regions should be vaccinated at least 10 days before travel.
• Other health threats, such as chikungunya and measles, are also present in the region.